In a study (n=368) of post-menopausal women with no known cardiovascular disease (CVD), published in the April issue of the American Journal of Cardiology, R. Calvo and his colleagues compared baseline levels of Uric Acid with Coronary Artery Calcium (CAC) scores obtained via Electron Beam Computed Tomography (EBCT) at baseline and again after 5 years. Those with higher levels of serum uric acid had more severe and/or more progression of CVD based on CAC results. The authors concluded that Uric Acid levels can be used as a marker of CAC (i.e., disease) progression.
Reference: Calvo RY, Araneta MR, Kritz-Silverstein D, et al. Relation of serum uric acid to severity and progression of coronary artery calcium in postmenopausal White and Filipino women (from the rancho Bernado study). Am J Cardiol 2014; 113:1154-1158. doi: 10.1016/j.amjcard.2013.12.022